Windtree Therapeutics, Inc. (WINT)
NASDAQ: WINT · Real-Time Price · USD
0.503
-0.006 (-1.24%)
Nov 22, 2024, 4:00 PM EST - Market closed
Windtree Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 4 | 4 | 7 | 45 | 87 | 174 | |
| Market Cap Growth | -70.47% | -43.61% | -85.53% | -47.73% | -50.23% | 8.77% | |
| Enterprise Value | 6 | 13 | 16 | 39 | 83 | 194 | |
| Last Close Price | 0.50 | 12.94 | 153.00 | 1444.50 | 4617.00 | 11474.99 | |
| PS Ratio | - | - | - | - | - | 880.79 | |
| PB Ratio | 0.09 | 1.09 | 0.66 | 1.08 | 1.25 | 2.33 | |
| EV/Sales Ratio | - | - | - | - | - | 982.20 | |
| Debt / Equity Ratio | 0.88 | 4.96 | 1.73 | 0.43 | 0.27 | 0.28 | |
| Asset Turnover | - | - | - | - | - | 0.00 | |
| Quick Ratio | 0.21 | 1.08 | 2.51 | 4.54 | 2.76 | 2.89 | |
| Current Ratio | 0.23 | 1.35 | 3.00 | 4.77 | 2.96 | 3.05 | |
| Return on Equity (ROE) | -150.80% | -302.78% | -151.11% | -121.39% | -45.08% | -38.41% | |
| Return on Assets (ROA) | -44.76% | -29.92% | -23.83% | -21.49% | -15.86% | -13.05% | |
| Return on Capital (ROIC) | -86.94% | -44.30% | -30.85% | -27.23% | -19.92% | -16.61% | |
| Earnings Yield | -258.77% | -548.17% | -597.35% | -149.08% | -37.52% | -15.75% | |
| FCF Yield | -289.16% | -363.41% | -296.56% | -52.77% | -29.50% | -14.25% | |
| Buyback Yield / Dilution | -368.05% | -515.24% | -27.27% | -58.11% | -43.25% | - | |
| Total Shareholder Return | -368.05% | -515.24% | -27.27% | -58.11% | -43.25% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.